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Brief Communication 
OXYGEN METABOLITE DETOXIFYING ENZYME LEVELS 
BLEOMYCIN-INDUCED FIBROTIC LUNGS 
IN 
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(Received l0 November 1987; Accepted 17 November 1987) 
Abstract--The activities of three enzymes cytosolic superoxide dismutase (SOD), catalase (CAT), and glutathione 
peroxidase (GSHP), and malonyldialdehyde (MDA), a by-product of lipid peroxidation, were determined in whole 
lungs of normal and bleomycin-treated rats. Two days after bleomycin treatment total lung SOD, CAT, and GSHP 
activities were significantly (19 < .025) depressed between 15 and 25%. The activities of all three enzymes increased 
4 days after bleomycin treatment with only SOD significantly increased at days 4 and 7. Total lung CAT activity 
remained near normal levels while GSHP activity increased only at day 28 (160.5%, p < .01) indicating a specificity 
of the response of lung SOD and GSHP levels. Total lung MDA levels were increased by 17% at 2 and 4 days 
(p < .05) after bleomycin treatment, and returned to normal levels at 7 and 28 days. These data suggest that 
impairment of the lung's ability to detoxify 02 metabolites may play an important role in the development of 
bleomycin-induced pulmonary fibrosis. 
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INTRODUCTION 
Interstitial pulmonary fibrosis is a frequent sequela of 
many forms of lung injury, which are associated with 
the generation of oxygen-derived free radicals and their 
metabolites.1-6 These observations suggest that the in- 
ability of the lung to inactivate reactive free radicals 
and their metabolites may play a role in the initiation 
of the fibrotic response. Bleomycin, a mixture of gly- 
copeptides derived from Streptomyces verticillus is a 
potent chemotherapeutic agent and is known to produce 
interstitial pulmonary fibrosis in humans 4 as well as 
experimental animals. 7 Using an established model of 
bleomycin-induced pulmonary fibrosis in adult rats, we 
examined in lung tissue the activities of three anti- 
oxidant enzymes cytosolic superoxide dismutase (SOD), 
catalase (CAT), and glutathione peroxidase (GSHP) in 
addition to malonyldialdehyde, a by-product of lipid 
peroxidation at different times after intratracheal in- 
stillation of bleomycin. 
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MATERIALS AND METHODS 
Reagents and animals 
Hydrogen peroxide (30% solution) was obtained from 
Mallintrodt Inc. (St. Louis, MO). Bleomycin (Ble- 
noxane R) was a generous gift of Bristol Laboratories 
(Syracuse, NY). Ail other chemicals were obtained 
from Sigma Chemical Co. (St. Louis, MO) and of 
analytical reagent grade unless otherwise specified. 
Groups of four rats (maie Fisher 344 pathogen-free 
rats (150-200 grams) from Charles River [Portage, 
Ml]) received bleomycin (1.5 units / animal) by intratra- 
cheal injection under ketamine (Ketalar R, Parke-Davis, 
Detroit, Ml) anesthesia as previously described. 7 Con- 
trol animais received sterile saline instilled 
intratracheally. 
Enzyme assays 
At specific time intervals after bleomycin admin- 
istration four bleomycin-treated and four control ani- 
mais were sacrificed and their lungs perfused with 10 
ml of saline. Each lung was isolated, minced, and 
homogenized with a polytron (Brinkman Instrument, 
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Westbury, NY) in 4 ml of phosphate-buffered saline 
(PBS), 5 mM EDTA, and 0.1% Triton X-100. 1.5 ml 
of homogenized suspension was removed to be assayed 
for MDA content. The remaining 2.5 ml were centri- 
fuged (105,000 x g, 60 min, 4°C), the supernatants 
removed, filtered through 0.65 Ixm filters and assayed 
for total lung protein. 8 Lung CAT activity was assayed 
by determining the initial rate of decrease in absorb- 
ance at 240 nm (e = 1.308 x 10 -4 ixM-~cm -~, for 
H202) after the addition of 20~1 lung supernatant into 
0.98 ml of 0.2 M H202 in 50 mM potassium phosphate 
buffer pli  7.0, at room temperature. 9 The cytosolic 
SOD activity in each lung was determined by the method 
of Misra and Fridovich. ~° One unit of SOD activity 
was defined as the amount of lung supernatant which 
produced 50% inhibition of the spontaneous auto-ox- 
idation of epinephrine to adrenochrome. The assay was 
performed in 0.05 M sodium carbonate buffer pli  10.2, 
c o n t a i n i n g  10 -4 M EDTA, at room temperature and 
monitored at a wavelength of 480 nm. Fifty percent 
inhibition was observed in the range of 10 to 30 ixl of 
lung extract. Glutathione peroxidase activity was de- 
termined by the method of Paglia and Valentine. ~~ 
Twenty txl of lung extract was added to a 1.0 ml re- 
action mixture containing 0.13 M sodium phosphate, 
pli  7.0 at room temperature, 0.013 M EDTA, .011 M 
sodium azide, .015 M glutathione (reduced form), 0.84 
mM NADPH, 1.0 unit/ml glutathione reductase, 0.22 
mM H20» The initial rate of decrease in absorbance 
was determined at 340 nm (e = 6.22 × 103M-]cm -1 
for NADPH). 
two factor mixed design (repeated measures on one 
factor) analysis of variance technique was used to de- 
termine p values between control and bleomycin-treated 
groups. ~~ 
RESULTS 
The relative amounts of MDA present in the lungs 
of bleomycin-treated animais as compared to control 
animais is shown in Figure 1. There was a small but 
significant increase in total thiobarbituric acid reactive 
material present in the lungs of the treated animals, 
reaching a maximum of 117% of control values (p < 
.05) at day 4 post-bleomycin instillation and returning 
to normal levels by days 7 and 28. When normalized 
to mg total lung protein, there is a significant increase 
in the levels of MDA (23.6% above control animais, 
p < .05) two days post-bleomycin treatment. This was 
followed by a decrease below control values of 15.8% 
at 4 days, 16.8% at 7 days, and 35.5% at 28 days after 
bleomycin treatment. 
Total lung cytosolic SOD activity was depressed 
(75.3% of control values p < .02) at day 2 after bleo- 
mycin treatment (Fig. 2). This was followed by an 
increase in SOD activity at day 4, reaching a maximum 
at day 7 (147.9% of control levels, p < .02) and re- 
turning towards control levels at day 28. When nor- 
malized per mg total lung protein, the SOD activity 
was attenuated similar to MDA, however, the changes 
were not significantly different from control values. 
Total lung catalase activity was decreased at 2 days 
MDA assay 
The malonyldialdehyde content of  lung homoge- 
nates was determined by assaying the quantity of thio- 
barbituric acid (TBA) reactive products present. ~2 1.5 
mis of 0.8% TBA in 10% trichloroacetic acid were 
added to 0.5 ml of each lung homogenate, vortexed, 
and placed in a boiling water bath for 10 minutes. The 
reaction mixtures were allowed to cool, 1.0 ml of 1 N 
NaOH added, and centrifuged at 2,000 xg for 20 min- 
utes. The absorbance of the supernatant was deter- 
mined at 532 nm and the quantity of MDA determined 
(e = 1.56 x 10»M-]cm ~). 
Statistical analysis 
Ail enzyme assays and MDA determinations were 
conducted in triplicate for each lung sample. Mean 
values for reach lung sample and mean values for each 
group of four bleomycin-treated and four control ani- 
mais were determined at each time point and the data 
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DAYS POST BLEOMYCIN TREATMENT 
Fig. 1. Effect of bleomycm treatment on lung MDA content. MDA 
levels in lungs of control and bleomycin-treated animais were de- 
termined. The percent change in lung MDA levels in bleomycin- 
treated animais compared to normal lungs was determined. O--Ç)  
= total lung MDA activity; 0 - - - - 0  = lung MDA activity/mg 
total lung protein; * = p < .05. 
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DAYS POST BLEOMYCIN TREATMENT 
Fig. 2. Effect of bleomycln treatment on lung SOD activity. SOD 
act]vlty m supernatants of homogenized lung was determined in both 
bleomycin-treated and control animals. The percent change in lung 
SOD activity in bleomycin-treated animals compared to controls was 
determined. 0 - - 0  = total lung SOD activity; 9 ~ - - - - O  = lung 
SOD actlvlty/mg total lung protein; * = p < .05. 
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OE DAYS POST BLEOMYCIN TREATMENT 
Fig. 4. Effect of bleomycin treatment on lung GSHP activity. GSHP 
activity was determined in supernatants of lung homogenates from 
bleomycin and control animals. The percent change in lung GSHP 
activity in bleomycin-treated animais compared to control animais 
was determined O - - O  = total lung GSHP activlty; 0 - - - - 0  = 
GSHP activity/mg total lung protein; * = p < .05. 
(75.9% of control values, p < 0.025) after bleomycin 
treatment, returning to control levels at days 4, 7, and 
28 (Fig. 3). When normalized per mg total lung pro- 
tein, there was a significant decrease in CAT activity 
after bleomycin treatment. An initial nadir of  27.1% 
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Fig. 3. Effect of bleomycin treatment on lung CAT activity. CAT 
activity was determined in supernatants of lung homogenates from 
bleomycin and control animais. The percent change in lung CAT 
activity in bleomycin-treated animals compared to control animals 
was determined. O - - O  = total lung CAT activity, 0 - - - - 0  = 
lung CAT activity/mg total lung protein; * = p < .05. 
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below control values (p < .02) was observed 4 days 
after bleomycin treatment. At 7 days the CAT activity 
per mg lung protein increased to 89.4% of  control 
levels and at 4 weeks decreased to 42.5% below control 
levels (p < .01). 
There was a decrease in total lung GSHP activity 
when compared to control levels (86.4%, p < .025) 
at day 2 after bleomycin treatment (Fig. 4). However,  
at days 4 and 7 posttreatment, there was variability in 
the content of  GSHP in whole lung extracts, which 
were not significantly different than control values. In 
contrast to catalase, there was a marked increase in 
total lung GSHP activity (160.5% of  control levels, p 
< 0.1) at day 28. When GSHP activity was determined 
per mg lung protein there was no difference between 
bleomycin-treated and control animals at 2 days. How- 
ever, the GHSP activity decreased at 4 and 7 days 
(32.7% below control values, p < .05) after treatment. 
At day 28, the GSHP activity per mg lung protein 
returned to normal levels. 
DISCUSSION 
During the first week post-bleomycin treatment there 
is a transient increase in total lung MDA. This occurs 
at the time of  greatest acute tissue injury. The apparent 
decrease in TBA reactive products when normalized 
per mg total lung protein at days 4 and 7 was most 
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likely due to increases in total lung protein resulting 
from the inflammatory infiltrate. The significant de- 
crease at day 28 was most likely the result of increases 
in total lung mass (usually 50% above controls) and 
protein, especially collagen which has been reported 
to be 80% greater than control values. 7 
Although there is no direct evidence for lipid per- 
oxidation occurring in bleomycin-injured lungs, it is 
well established that free radicals have the potential to 
generate lipid peroxides and MDA.12 There are several 
potential sources of free radical production in the lungs 
of bleomycin-treated animais. Bleomycin has been 
shown to generate free radicals in vitro and to alter 
DNA structure through the action of an iron-bleomycin 
complex. 14 However, since the quantity of bleomycin 
used to induce lung injury is relatively small ( 1.5 units/ 
animal), it is more likely that the increased levels of 
MDA are secondary to the inflammatory infiltrate. 15 
An alternative explanation for the rise in total lung 
MDA content is the marked decrease in oxygen me- 
tabolite detoxifying enzyme activities occurring after 
bleomycin treatment. Lipid peroxidation within the lung 
may result from oxygen metabolite generation within 
resident lung cells whose ability to metabolize nor- 
mally occurring reactive products is impaired. After 
one week post-bleomycin treatment the MDA levels 
returned to control levels. This corresponds with the 
return to normal and/or increased levels of 02 detox- 
ifying enzyme activities. The relative decrease in the 
total lung activities of SOD, CAT, and GSHP after 
bleomycin treatment, despite the presence of intra-al- 
veolar hemorrhage and inflammation suggests an in- 
activation (possibly due to oxygen metabolites L6) and/ 
or decreased synthesis (potentially secondary to bleo- 
mycin-induced DNA destruction) of these enzymes. 
This would potentially predispose the lung to injury 
by free radicals. 
After the initial decrease in total lung SOD and GSHP 
levels there was a significant increase above control 
values in both enzyme activities atone and four weeks, 
respectively. This increase in enzyme activities is sim- 
ilar to that observed with experimental models of 
hyperoxia-induced lung injury. ~7.~8 However, there ap- 
pears to be a specificity in the response of bleomycin- 
treated animais, since lung catalase levels were not 
increased above control values. In conclusion, the data 
demonstrate a time-dependent increase in MDA con- 
tent and suppression of oxygen metabolite detoxifying 
enzymes in the lung after bleomycin treatment sug- 
gesting a role for oxygen metabolites and free radicals 
in bleomycin-induced lung injury. 
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